BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Biotech Bay

  California Life Sciences Institute (CLSI) Names Winner Of Amgen Bay Area BioGENEius Competition

  April 18, 2016

   · 

  4 min read
• Drug Development

  RedHill Biopharma Announces Positive FDA Meeting On RHB-105 Path To Approval And Planned Confirmatory Phase III Study For H. Pylori Infection

  April 18, 2016

   · 

  7 min read
• Business

  Enterome In-Licenses Novel Compounds From Vertex To Treat Microbiome-Related Inflammatory Bowel Diseases

  April 18, 2016

   · 

  2 min read
• Policy

  Arbutus’ LNP Licensee Alnylam Receives Accelerated Assessment of Patisiran from European Medicines Agency (EMA)

  Accelerated assessment may provide a reduced review timeline from 210 to 150 days once the marketing authorization application (MAA) is filed and validated, which Alnylam intends to file by year-end 2017.

  April 18, 2016

   · 

  3 min read
• Technical University Of Munich Release: Mechanics Of The Cell

  April 18, 2016

   · 

  4 min read
• Biotech Beach

  X2 Biosystems Awarded Pioneer In Healthcare Technology Award By The Society For Brain Mapping And Therapeutics

  April 18, 2016

   · 

  5 min read
• DiaCarta To Launch Pangaea Liquid Biopsy Test In The U.S. And China

  April 18, 2016

   · 

  1 min read
• Biotech Beach

  Endologix Announces First Patients In Japan Treated With Nellix EndoVascular Aneurysm Sealing System

  April 18, 2016

   · 

  3 min read
• Drug Development

  Merus To Present Interim Clinical Data From Ongoing Phase I/II Clinical Trial Of Its Lead Bispecific Antibody Candidate, MCLA-128, At The AACR 2016 Annual Meeting

  April 18, 2016

   · 

  4 min read
• Drug Development

  Titan Pharma Announces Presentation Of Probuphine Phase III Data At American Society Of Addiction Medicine Annual Conference

  April 18, 2016

   · 

  6 min read